PDIA3 and metastatic neoplasm: The results showed that there was a significant difference in its expression between normal gastric mucosa and gastric gland cancer cells in primary and metastatic tumors, and the low expression of PDIA3 in tumors was indeed related to the increase of tumor invasion depth, the advance of overall clinical stage of disease, and the decrease of postoperative survival rate.